全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2015 

人舌鳞癌细胞SOCS1基因沉默对细胞增殖和化疗药物敏感性的影响
Effects of Suppressor of Cytokine signaling-1 Silencing on the Proliferation and Chemotherapeutic Drugs Sensitivity of Human Squamous Cell Carcinoma of Tongue.

Keywords: 人舌鳞癌,基因沉默,细胞增殖,化疗药物,细胞因子信号转导蛋白抑制因子,
Human squamous cell carcinoma of tongue
,Gene silencing ,Cell proliferation ,Chemotherapeutic drugs, Suppressor of cytokine signaling proteins

Full-Text   Cite this paper   Add to My Lib

Abstract:

摘要 目的:在人舌鳞癌细胞中观察细胞因子信号转导抑制因子1(SOCS1)沉默对细胞增殖及化疗药物敏感性的影响,探讨SOCS1作为舌鳞癌治疗靶点的研究。方法:western blot、PCR及定量PCR验证SOCS1干扰序列沉默人舌鳞癌细胞系CAL27中SOCS1的表达; MTT法检测舌鳞癌细胞对化疗药物敏感性的变化;细胞计数的方法观察细胞的增殖速度;采用流式细胞术的方法检测细胞周期的变化。结果:将SOCS1干扰序列转染CAL27细胞后,SOCS1 mRNA及蛋白表达水平均明显下降。沉默SOCS1表达后,化疗药物卡铂和紫杉醇对CAL27细胞的半数抑制浓度(IC50)均显著降低(P<0.01);转染72 h后CAL27细胞数量较对照组显著减少(P<0.05);SOCS1表达抑制后CAL27细胞G0/G1期细胞比例明显升高,而S期和G2/M期细胞比例明显减小,与对照组比较差异均有统计学意义(P<0.05)。结论:SOCS1表达抑制后,人舌鳞癌细胞株CAL27的增殖能力下降,并且对化疗药物的敏感性增强

References

[1]  Ge D, Gao AC, Zhang Q, et al. LNCaP prostate cancer cells with autocrine interleukin-6 expression are resistant to IL-6-induced neuroendocrine differentiation due to increased expression of suppressors of cytokine signaling [J]. Prostate, 2012, 72(12)∶1306-1316
[2]  Gui Y, Yeganeh M, Cepero-Donates Y, et al. Regulation of MET Receptor Signaling by SOCS1 and its Implications for Hepatocellular Carcinoma [J]. Curr Pharm Des, 2013, [Epub ahead of print]
[3]  Scutti JA, Matsuo AL, Pereira FV, et al. Role of SOCS-1 Gene on Melanoma Cell Growth and Tumor Development [J]. Transl Oncol, 2011, 4(2)∶101-109
[4]  Sun Q, Xiang RL, Yang YL, et al. Suppressor of cytokine signaling 1 protects rat pancreatic islets from cytokine-induced apoptosis through Janus kinase/signal transducers and activators of transcription pathway [J]. Chin Med J (Engl), 2013, 126(21)∶4048-4053
[5]  Satou R, Miyata K, Gonzalez-Villalobos RA, et al. Interferon-γ biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells [J]. FASEB J, 2012, 26(5)∶1821-1830
[6]  Mansell A, Smith R, Doyle S L, et al. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation [J]. Nat Immunol, 2006, 7(2)∶148-155
[7]  Heo MB, Cho MY, Lim YT. Polymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells [J]. Acta Biomater, 2014, 10(5)∶2169-2176
[8]  刘炜炜,高尚,王战鑫,等.L-18 转染人舌癌 CRLl623 细胞及抗瘤作用的初步探讨[J].口腔医学研究,2013,29(3)∶233-237
[9]  Huang C, Li H, Wu W, et al. Regulation of miR-155 affects pancreatic cancer cell invasiveness and migration by modulating the STAT3 signaling pathway through SOCS1 [J]. Oncol Rep, 2013, 30(3)∶1223-1230
[10]  Laner-Plamberger S, Wolff F, Kaser-Eichberger A, et al. Hedgehog/GLI signaling activates suppressor of cytokine signaling 1 (SOCS1) in epidermal and neural tumor cells [J]. PLoS One, 2013, 8(9)∶e75317
[11]  Gregory B Lesinski, Jason M Zimmerer, Melanie Kreiner, et al. Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells [J]. BMC Cancer, 2010, 142(10)∶1-10

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133